U.S. to study whether longer Paxlovid course needed to combat reinfections
Reuters
5/18/2022
© Reuters/PFIZER
FILE PHOTO: Pfizer's COVID-19 pill Paxlovid is packaged in Ascoli
By Michael Erman
(Reuters) - The U.S. National Institutes of Health is in talks with Pfizer Inc about studying whether a longer course of the drugmaker's COVID-19 antiviral treatment Paxlovid is needed to prevent reinfections, top U.S. infectious diseases expert Dr. Anthony Fauci said on Wednesday.
-
Yemen's mountain of trash piles on the country's woes
Reuters -
Ukraine official: Luhansk could fall to Russia in matter of days
TODAY -
Uvalde school police chief Pete Arredondo resigns from city council
TODAY -
Pope prays for peace in Ukraine
Reuters -
Bodycam footage to be released in Ohio shooting of Jayland Walker
TODAY -
Biden spends July 4 at Camp David after difficult week
TODAY -
Aerial footage shows heavily flooded parts of Sydney
Reuters -
Fighting intensifies in Kharkiv, continues in 'epicentre' Donbas - Zelenskiy
Reuters -
The Fallout from the Supreme Court's Latest Rulings
MSNBC -
What Can Congress Do To Help Save Women's Reproductive Rights
MSNBC -
Supreme Court’s latest radicalization goes far beyond abortion rights
MSNBC -
March after deadly police shooting of Black man in Ohio
Reuters -
The latest increase in anti-LGBTQ legislation is taking a toll on queer youth
MSNBC -
Video shows group wielding Patriot Front flags marching through Boston
CNN -
Ex-Secret Service agent reacts to testimony: Did we expect anything less from Trump?
CNN -
NATO to expand alliance and boost defenses in Europe
Reuters
-
Yemen's mountain of trash piles on the country's woes A colossal pile of waste, which includes dangerous untreated medical waste, just outside Yemen's capital poses a threat to the environment and water supplies, officials say. Lauren Anthony reports.
Reuters
-
Ukraine official: Luhansk could fall to Russia in matter of days Russia appears poised to capture one of the last strongholds in eastern Ukraine. An advisor to Ukrainian President Zelenskyy says it could be just a matter of days before the city in Luhansk falls.
TODAY
-
Uvalde school police chief Pete Arredondo resigns from city council Pete Arredondo, the embattled school district police chief in Uvalde, Texas, has resigned from the city council. Arredondo was sworn in to that position just days after the massacre at Robb Elementary School, where he is accused of failing to mount a rapid police response.
"We're going to be planning what studies we're going to be doing relatively soon, within the next few days" in order to determine whether or not a longer course is needed, Fauci said during a White House COVID-19 briefing.
Rising COVID-19 cases in the United States are driving up use of therapeutics, with more than 660,000 courses of Paxlovid pills administered in the country so far.
Some patients have reported that COVID symptoms recurred after completing the five-day course of treatment and experiencing improvement, but exactly how many have experienced such a rebound is unclear.
In Pfizer's clinical trial, around 2% of recipients who received the two-drug treatment saw an increase in viral load after completing the standard course, compared with around 1.5% of placebo recipients.
White House COVID-19 response coordinator Dr. Ashish Jha said that data was compiled when Delta was the dominant variant of the coronavirus, and it is unclear whether reinfections are more common with Omicron now predominant.
Jha said that reinfections do not seem to hamper Paxlovid's ability to reduce hospitalizations and deaths from COVID-19.
Pfizer has suggested that a second five-day course of Paxlovid could treat reinfections. The U.S. Food and Drug Administration said there is currently no evidence to support taking a second five-day course or a 10-day course of the pills.
(This story refiles to fix typographical error in third paragraph)
(Reporting by Michael Erman; Editing by Bill Berkrot)
Reuters
